Quidel, a diagnostic testing solutions provider, has received CE mark approval for its Sofia strep A fluorescent immunoassay (FIA) test for use with its Sofia analyser.
The Sofia analyser and Sofia strep A FIA integrates lateral flow technology, fluorescent chemistry, failure alert and fail-safe systems to provide accurate diagnostic result.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Quidel president and CEO Douglas Bryant said in combination with their Sofia influenza A+B FIA, Sofia strep A FIA will provide healthcare providers with added testing versatility during this respiratory disease season.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
